MedPath

Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

Phase 3
Completed
Conditions
Hypercholesterolemia
Atherosclerotic Disease
Coronary Disease
Registration Number
NCT00090168
Lead Sponsor
Organon and Co
Brief Summary

A 6-week treatment study to compare the reduction in cholesterol of two drugs MK0653A+Simvastatin for high cholesterol, in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
435
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
LDL-C lowering
Secondary Outcome Measures
NameTimeMethod
Total cholesterol (TC) lowering
© Copyright 2025. All Rights Reserved by MedPath